Advisor Group’s Sonoma Pharmaceuticals SNOA Stock Holding History

Advisor Group’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1	Closed	–	–	5408
2019 Q2	$0	Buy	+1	New	+$154	﹤0.01%	5349
2017 Q1	–	Sell	-5	Closed	-$5K	–	4792
2016 Q4	$5K	Hold	5	–	–	﹤0.01%	3947
2016 Q3	$4K	Buy	+5	New	+$3.75K	﹤0.01%	4005

Other funds holding SNOA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Advisor Group's SNOA Position: Q3 2019 in Review

Advisor Group sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2019, closing a stake of 1 share.

Advisor Group first reported a position in SNOA in Q3 2016 and held it in 3 quarters. The position peaked at $5K in Q4 2016. 13 funds tracked by Wall St. Rank hold SNOA as of Q3 2019.

Advisor Group reported no remaining Sonoma Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Advisor Group sold 1 Sonoma Pharmaceuticals share in Q3 2019.
Advisor Group first reported a position in Sonoma Pharmaceuticals in Q3 2016 and held it in 3 quarters.
Advisor Group's Sonoma Pharmaceuticals position peaked at $5K in Q4 2016.
13 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2019.

Based on Advisor Group's 13F filing for Q3 2019, filed 13 Nov 2019.